Alan Rubino
Director/Board Member at VERICEL CORPORATION
Net worth: 1 M $ as of 2024-03-30
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Harmel Rayat | M | 63 | 6 years | |
Kevin Richardson | M | 54 | 19 years | |
Michael F. Snape | M | - |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | 9 years |
Joseph Mara | M | 49 | 3 years | |
Stephen Sullivan | M | 77 | 20 years | |
Robert Zerbe | M | 73 | 18 years | |
Dominick Colangelo | M | 60 | 11 years | |
Leonard Mazur | M | 79 |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 16 years |
Robert C. Getts | M | - |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
James M. Kadushin | M | - |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Heidi Hagen | F | 55 | 11 years | |
Anthony Stolarski | M | 52 | 8 years | |
Michael Halpin | M | 62 | 7 years | |
Sean Flynn | M | 50 | 5 years | |
Lisa M. Goldman | F | - |
HealthCare Institute of New Jersey
| 10 years |
Saiyed Mahmood | M | 50 |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | - |
Kevin T. Rigby | M | - |
HealthCare Institute of New Jersey
| 12 years |
Steven Gilman | M | 71 | 9 years | |
Kevin McLaughlin | M | 67 | 9 years | |
Lisa Wright | F | 49 | 3 years | |
Julia Jones | F | - |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | 3 years |
Paul Wotton | M | 63 | 9 years | |
Jeffrey S. Sherman | M | 68 |
HealthCare Institute of New Jersey
| 10 years |
Yin Becker | F | 60 |
HealthCare Institute of New Jersey
| 10 years |
Phil Nikolayuk | M | - | 9 years | |
Patrick J. Fowler | M | - | 3 years | |
Roland DeAngelis | M | - | - | |
Brian McVeigh | M | 51 |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | 6 years |
Raymond Sacchetti | M | - |
HealthCare Institute of New Jersey
| 10 years |
Eric Burns | M | - | - | |
Julie Downs | F | - | - | |
Joseph Horrigan | M | - |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology AMO Pharma Ltd. engages in the development of biopharmaceutical products. It develops and identifies and advance therapies for people affected by serious and debilitating diseases, particularly rare or orphan diseases. The company was founded by Michael F. Snape on February 10, 2015 and is headquartered in Leeds, United Kingdom. | - |
Iulian Cioanta | M | 60 | 17 years | |
Haskell Berman | M | - |
HealthCare Institute of New Jersey
| 13 years |
Mark Trudeau | M | 62 |
HealthCare Institute of New Jersey
| - |
Vijay Aggarwal | M | 75 |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Anthony Hooper | M | 69 |
HealthCare Institute of New Jersey
| - |
John Chiminski | M | 60 |
HealthCare Institute of New Jersey
| - |
Jayne C. Gershkowitz | F | - |
HealthCare Institute of New Jersey
| - |
Tony H. Wild | M | 75 |
HealthCare Institute of New Jersey
| - |
S. Arieh Zak | M | 59 |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Jo Schweinle | M | - | 4 years | |
Wendy M. Lazarus | F | - |
HealthCare Institute of New Jersey
| - |
Steve Issenman | M | - |
HealthCare Institute of New Jersey
| 13 years |
Cynthia L. Sullivan | F | 68 |
HealthCare Institute of New Jersey
| 15 years |
Peter Stegagno | M | 63 | 18 years | |
Patrick Zenner | M | 77 |
HealthCare Institute of New Jersey
| - |
Neil Larimer | M | - |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 14 years |
John C. Simons | M | - |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Charles S. Lachman | M | - |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Russ Fein | M | - |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | - |
Caryn Cramer-Babycz | F | - | 13 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sydney Colin Neill | M | 77 | 6 years | |
Michael R. Garone | M | 66 | 9 years | |
Tim Mayleben | M | 63 | 8 years | |
Michael W. Elliston | M | - | - | |
Lisa Sundstrom | F | 54 | - | |
James A. Meer | M | 78 | 2 years | |
Nelson M. Sims | M | 76 | 9 years | |
Michael Schuler | M | - |
Rutgers State University of New Jersey
| 7 years |
Brian D. Gibson | M | 45 | 3 years | |
Barry J. Jenkins | M | 61 | 6 years | |
Scott Durbin | M | 55 | 1 years | |
Kaiyo Nedd | M | 50 | 1 years | |
Joseph J. Krivulka | M | 73 |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 11 years |
Gerald D. Brennan | M | 73 | 4 years | |
R. Douglas Armstrong | M | 70 | 19 years | |
James Marino | M | 74 |
Rutgers State University of New Jersey
| 10 years |
Christopher M. Cashman | M | 56 | 3 years | |
Jonathan M. Kuller | M | - |
Rutgers State University of New Jersey
| 8 years |
Thomas Price | M | 68 | 1 years | |
Kathleen McDede | F | - | - | |
Patsy J. Trisler | F | 74 | 6 years | |
Michael J. Farrell | M | 45 |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ.
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 4 years |
Kenneth Kirkland | M | 82 | 8 years | |
Jeffrey Heller | M | - |
Rutgers State University of New Jersey
| 6 years |
Thomas J. Cafferty | M | - |
Rutgers State University of New Jersey
| 7 years |
Allan Harvey Cohen | M | 73 |
Rutgers State University of New Jersey
| 5 years |
Sharon M. Watling | M | 60 | - | |
Bernard Laurel | M | - | - | |
Tod Borton | M | - | - | |
Thomas H. Robinson | M | 65 | 7 years | |
Carl Sailer | M | 54 |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ | 10 years |
Saul Zimmerman | M | - |
Rutgers State University of New Jersey
| 7 years |
Gerard Michel | M | 60 | 6 years | |
Bryan B. Sendrowski | M | - |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Akrimax Pharmaceuticals LLC manufactures medicines for metabolic syndrome. The company's products include Inderal and Lo/Ovral. The company was founded in 2007 by Joseph J. Krivulka and Leonard L. Mazur and is headquartered in Cranford, NJ
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology New American Therapeutics, Inc. is a pharmaceutical company, which acquires, markets and develops products in cardiovascular area. The company is headquartered in Parsippany, NJ. | 4 years |
James Andrew Cour | M | 68 | 2 years | |
Douglas B. Campbell | M | - |
Rutgers State University of New Jersey
| 6 years |
Ronald M. Cresswell | M | 89 | 4 years | |
Charles Newhall | M | 79 | 6 years | |
John Fritzen Nemelka | M | 59 | 13 years | |
Srini Akkaraju Akkaraju | M | 56 | 5 years | |
Alan E. Delahoy | M | - |
Rutgers State University of New Jersey
| 4 years |
George Dunbar | M | 77 | 4 years | |
William Joseph Daley | M | - |
Rutgers State University of New Jersey
| 5 years |
Joseph Chiarelli | M | 77 | 1 years | |
Bob Cook | M | 68 | 1 years | |
Robert M. Pickus | M | 70 |
Rutgers State University of New Jersey
| 7 years |
Anthony Evnin | M | 83 | 6 years | |
Douglas A. Duchak | M | - |
Rutgers State University of New Jersey
| 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 96 | 96.00% |
United Kingdom | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Alan Rubino
- Personal Network